- Home
- RYOJ vs ZTEK Comparison
RYOJ vs ZTEK Comparison
Compare RYOJ & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYOJ | ZTEK |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | Japan | Canada |
| Employees | N/A | N/A |
| Industry | Professional Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.9M | 59.5M |
| IPO Year | 2024 | 2022 |
Fundamental Metrics
Financial Performance| Metric | RYOJ | ZTEK |
|---|---|---|
| Price | $5.85 | $0.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 47.6K | ★ 106.9K |
| Earning Date | 12-15-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.56 | $0.37 |
| 52 Week High | $11.43 | $1.24 |
Technical Indicators
Market Signals| Indicator | RYOJ | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 60.65 | 43.28 |
| Support Level | $2.00 | $0.55 |
| Resistance Level | $6.35 | $0.74 |
| Average True Range (ATR) | 0.61 | 0.05 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 86.38 | 5.27 |
Price Performance
Historical ComparisonAbout RYOJ rYojbaba Co. Ltd.
rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.
About ZTEK Zentek Ltd.
Zentek Ltd is engaged in developing opportunities in the graphene and related nano-materials industry based on its intellectual property, patents, and Albany graphite. The Company's operating segments are Intellectual Property Development, Biotech, and Albany Project. Intellectual Property Development includes the manufacturing and distribution of graphene-related products. Biotech includes service revenue generated through aptamer technology. The Albany Project includes the exploration and evaluation of assets and mineral exploration activities.